Clinical Trial Update: Study of Bacteroides Thetaiotaomicron in Young People Aged 16 to 18 Years With Stable Crohn's Disease [NA]

View source ↗

Summary

An update indicates that the study evaluating Bacteroides thetaiotaomicron in young people aged 16 to 18 with stable Crohn's disease has completed. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Bacteroides thetaiotaomicron (Bacteroides thetaiotaomicron)

Snippet

Sponsor: 4D pharma plc | Conditions: Crohn's Disease | NA | Status: COMPLETED